•ブロッキングバッファー(1倍), 22.5 mL •ポリ-HRP標識ヤギ抗ウサギ二次抗体(1倍), 22.5 mL •Alexa Fluorチラミド試薬 •過酸化水素(安定化3%溶液), 28.5 mL •反応バッファー(20倍), 6 mL •反応停止液, 8 mg •ジメチルスルホキシド(DMSO), 200 µL
保存場所2~8℃指示通りに保存した場合、製品は受け取り後6ヶ月間安定しています。
よくあるご質問(FAQ)
With a SuperBoost tyramide kit, I got excessive and non-specific labeling. What can I do to limit background and acquire a more localized labeling?
To limit background, we recommend performing a pre-blocking step with 3% H2O2 for 60 mins to inactivate endogenous peroxidases. To limit the localization of labeling, we recommend optimizing the final concentration of the primary and secondary antibodies and the dye-tyramide. You may also limit the incubation time of the dye-tyramide on the sample.
How are SuperBoost tyramide kits different from the original TSA labeling kits?
The SuperBoost tyramide kits utilize poly-HRP labeled antibodies. This provides a greater number of horseradish peroxidase (HRP) molecules per antibody. The original kits used antibodies and streptavidin that were directly conjugated with HRP and thus, limited the number per antibody or streptavidin.
Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway.
Authors:Deshors P, Toulas C, Arnauduc F, Malric L, Siegfried A, Nicaise Y, Lemarié A, Larrieu D, Tosolini M, Cohen-Jonathan Moyal E, Courtade-Saidi M, Evrard SM
Journal:Cell Death Dis
PubMed ID:31659157
'Glioblastomas (GBM) are brain tumors with a poor prognosis despite treatment that combines surgical resection and radio-chemotherapy. These tumors are characterized by abundant vascularization and significant cellular heterogeneity including GBM stem-like cells (GSC) which contribute to tumor aggressiveness, resistance, and recurrence. Recent data has demonstrated that GSC are directly involved ... More
Optimization of prostate cancer cell detection using multiplex tyramide signal amplification.
Approximately 29?000 men die of prostate cancer (PCa) each year in the United States, and 90% to 100% of them are due to incurable bone metastasis. It is difficult to determine (1) when PCa disseminates in the natural history of the disease; (2) where cancer cell disseminates before becoming overt ... More